Tian, P., Feng, Y., & Tao, L. (2024). LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI. Chemical Biology & Drug Design, 103(1), 1. https://doi.org/10.1111/cbdd.14424
Chicago Style (17th ed.) CitationTian, Ping, Yuanyuan Feng, and Ling Tao. "LINC00460 Knockdown Sensitizes Cervical Cancer to Cisplatin by Downregulating TGFBI." Chemical Biology & Drug Design 103, no. 1 (2024): 1. https://doi.org/10.1111/cbdd.14424.
MLA (9th ed.) CitationTian, Ping, et al. "LINC00460 Knockdown Sensitizes Cervical Cancer to Cisplatin by Downregulating TGFBI." Chemical Biology & Drug Design, vol. 103, no. 1, 2024, p. 1, https://doi.org/10.1111/cbdd.14424.
Warning: These citations may not always be 100% accurate.